Key result
Addition of bromocriptine bid to standard heart failure therapy in a woman with severe peripartum cardiomyopathy led to recovery of LVEF from 15% to 60% and functional class I at 2 months.
Why the study?
Does bromocriptine improve symptoms and left ventricular ejection fraction in severe peripartum cardiomyopathy?
Case Report (n=1)
Does bromocriptine improve symptoms and left ventricular ejection fraction in severe peripartum cardiomyopathy?
The addition of bromocriptine to standard heart failure therapy may facilitate rapid and complete recovery of left ventricular function in severe peripartum cardiomyopathy.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating in peripartum cardiomyopathy; randomized trials needed before any practice change.
Peripartum cardiomyopathy (PPCM) is a potentially devastating cause of heart failure that affects women late in pregnancy or in early puerperium. Recent findings showed that a 16 kDa fragment of prolactin may induce myocardial damage, and this offered a new option of treating PPCM by blocking prolactin with bromocriptine. We report on a 35-year-old woman with a twin gravidity who gave birth to two healthy boys at day 36/6 and developed a potentially fatal PPCM. Within 3 days since delivery she suffered from severe symptoms of heart failure (orthopnoea, pleural and pericardial effusion, reduced systolic function LVEF 15%). Bromocriptine 2.5 mg bid was added to standard heart failure therapy at day 6 after delivery, and within a week the patient recovered to NYHA functional class II. 2 months later she presented in a good state, NYHA class I, and MRI confirmed an LVEF of 60%. Balancing the potential side effects of bromocriptine against the very poor prognosis in severe PPCM our case supports the use of bromocriptine as a specific novel therapy.
No takes yet. Share an insight, caveat, or question.
Habedank et al. (2008) conducted a case report in Peripartum cardiomyopathy (n=1). Bromocriptine was evaluated on Recovery of NYHA functional class and LVEF. Addition of bromocriptine bid to standard heart failure therapy in a woman with severe peripartum cardiomyopathy led to recovery of LVEF from 15% to 60% and functional class I at 2 months.
Synapse has enriched 10 related papers. Consider them for comparative context: